The Effect of 3-Week Consumption of Soya Beverage Enriched With Plant Sterols on Serum LDL-C
The Effect of Soya Beverage Fortified With Plant Sterol on Major Serum Lipids in Normocholesterolemic, Healthy Southern Chinese Individuals
1 other identifier
interventional
201
1 country
1
Brief Summary
This is a local, single-center, two-arm, randomized, double-blind, placebo-controlled clinical trial that examines the LDL-C-lowering effect of the consumption of a soya beverage enriched with plant sterol for 3 weeks. This study also examines if there is other health-benefits by consuming the plant sterols fortified soya beverage in terms of serum total triglyceride, total and HDL cholesterol, other cardiometabolic risk factors and musculoskeletal-related traits including handgrip strength, gait speed, peak expiratory flow rate, bio-impedance and body balance.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2016
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2016
CompletedFirst Submitted
Initial submission to the registry
August 14, 2016
CompletedFirst Posted
Study publicly available on registry
August 29, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2017
CompletedResults Posted
Study results publicly available
September 21, 2017
CompletedMay 3, 2018
May 1, 2018
9 months
August 14, 2016
May 20, 2017
May 2, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Mean of Serum Low-density Lipoprotein Cholesterol (LDL-C) Via Blood Test at Baseline and Week 3
From baseline to week 3
Secondary Outcomes (14)
Change of Low Density Lipoprotein Cholesterol (LDL-C) Via Blood Test at Baseline and Week 3
From baseline to week 3
Change of High-density Lipoprotein Cholesterol (HDL-C) Via Blood Test at Baseline and Week 3
From baseline to week 3
Change of Total Cholesterol Via Blood Test at Baseline and Week 3
From baseline to week 3
Change of Triglycerides (TAG) Via Blood Test at Baseline and Week 3
From baseline to week 3
Change of Serum Creatinine Via Blood Test at Baseline and Week 3
From baseline to week 3
- +9 more secondary outcomes
Study Arms (2)
Plant sterols-enriched soya beverage provided by Vitasoy
EXPERIMENTALDaily consumption of 2g of plant sterols as provided by one pack of 250 ml of plant sterols-enriched soya beverage for consecutive 3 weeks, each pack consumed once with main meal (i.e breakfast, lunch or dinner).
Soya beverage provided by Vitasoy
PLACEBO COMPARATORDaily consumption of one pack of 250 ml of soya beverage (without plant sterols) for consecutive 3 weeks, each pack consumed once with main meal (i.e breakfast, lunch or dinner).
Interventions
the study product is a 2g plant sterols-enriched in 250ml soya beverage
the placebo product is a 250 ml soya beverage
Eligibility Criteria
You may qualify if:
- Southern Chinese male or female ≥ 18 years;
- In good general health as evidenced by medical history;
- Have the ability to understand the requirements of the study, provide written informed consent, including consent for the use and disclose of research-related health information, and comply with the study data collection procedures. Provide signed and dated informed consent form
You may not qualify if:
- Subject with familial hypercholesterolemia;
- On regular medication(s) which affect gastrointestinal functions and blood lipids level for the past 3 months, such as, but not limited to:
- Antibiotics of \>1 week duration
- GI related medications such as antacids
- Having blood lipid lowering medications such as statins, selective cholesterol absorption inhibitors (e.g. ezetimibe), fibrates, niacin, resins, omega- 3
- Heavy-smokers (more than 1 pack per day)
- Subject with heavy alcohol intake (\>40 g/day for men ; \>30 g/day for women) (32), or having history of alcohol abuse within 12 months prior to the study
- Subjects with taste aversion to placebo/intervention soya beverages
- Subject refusing to stop the consumption of plant sterols-enriched products if any during the study (other than the studied product) or having regular consumption of sterols/stanols cholesterol-lowering supplements/functional foods or other related products such as:
- Sterol/ Stanol - containing margarines, milk, yoghurt drink and soya beverages
- Sterol / Stanol supplements
- Fish oils \& omega-3 supplements
- Subject receiving systemic treatment or topical treatment likely to interfere with evaluation of the study parameters
- Pregnancy or lactation
- Having soy allergy
- +12 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam
Hong Kong, Hong Kong
Related Publications (1)
Chau YP, Cheng YC, Sing CW, Tsoi MF, Cheng VK, Lee GK, Cheung CL, Cheung BMY. The lipid-lowering effect of once-daily soya drink fortified with phytosterols in normocholesterolaemic Chinese: a double-blind randomized controlled trial. Eur J Nutr. 2020 Sep;59(6):2739-2746. doi: 10.1007/s00394-019-02119-w. Epub 2019 Oct 23.
PMID: 31642984DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr Cheung Ching Lung
- Organization
- The University of Hong Kong
Study Officials
- PRINCIPAL INVESTIGATOR
Bernard Man Yung Cheung
Li Ka Shing Faculty of Medicine, The University of Hong Kong
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Department of Medicine, HKU
Study Record Dates
First Submitted
August 14, 2016
First Posted
August 29, 2016
Study Start
May 1, 2016
Primary Completion
February 1, 2017
Study Completion
February 1, 2017
Last Updated
May 3, 2018
Results First Posted
September 21, 2017
Record last verified: 2018-05